Microbiome Firm Second Genome Completes $5M Series A Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Microbiome technology firm Second Genome today announced the closing of a Series A financing round that raised $5 million.

The round was co-led by new investors Advanced Technology Ventures and Morgenthaler Ventures, as well as existing investors Wavepoint Ventures, Seraph Group, and individual investors.

The company, which was founded in 2009 as PhyloTech, also said that Mike Carusi of ATV and Jason Lettmann of Morgenthaler have joined its board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.